Diabetes Management

Diabetes management is about knowing where you are today and where you’re headed. Lab tests show short- and long-term glucose control and check the body systems diabetes can affect—heart, kidneys, nerves, and liver. A proactive plan usually starts with A1c for the past 2–3 months, fructosamine for the past 2–3 weeks, and fasting or post-meal glucosefor the “right now” view. To manage risk, add kidney tests (creatinine/eGFR and urine albumin/creatinine ratio), a lipid panel, and a liver panel. When questions remain, insulinC-peptide, and autoantibodi... See more

  • Page
  • 1
  • of
  • 5
  • Total Rows
  • 121
Name Matches
 The Diabetes Management - Basic panel is a fundamental tool designed to help monitor and manage diabetes effectively. This panel includes a series of tests that provide a comprehensive overview of a patient's metabolic status, blood glucose control, and kidney function. By assessing these key markers, healthcare providers can evaluate the current state of a patient's diabetes, identify potential complications early, and adjust treatment plans to ensure optimal management of the disease.
Serum, Blood
Phlebotomist

 The Diabetes Management - Basic Plus panel is an enhanced diagnostic tool designed to provide a more comprehensive assessment of diabetes management compared to the basic panel. This panel includes tests that not only monitor blood glucose control and kidney function but also provide insights into blood health and lipid metabolism. By expanding the range of biomarkers assessed, this panel helps healthcare providers to better understand the overall health status of diabetic patients and to identify potential complications at an early stage.
Blood, Serum
Phlebotomist

 The Diabetes Management - Advanced panel is an extensive diagnostic tool designed to provide a thorough evaluation of a patient’s diabetic status and associated health risks. This panel includes a comprehensive range of tests that assess blood glucose control, kidney function, lipid metabolism, insulin levels, and overall metabolic health. The combination of these tests offers a holistic view of a diabetic patient's condition, enabling healthcare providers to develop effective management and treatment plans.
Blood, Serum
Phlebotomist

 The Diabetes Management - Comprehensive panel is an extensive diagnostic tool designed to provide a thorough evaluation of a patient's diabetic status and associated health risks. This panel includes a broad range of tests that assess blood glucose control, kidney function, lipid metabolism, inflammation, and overall metabolic health. By offering a detailed picture of a diabetic patient's condition, healthcare providers can develop and refine effective management and treatment plans to optimize patient outcomes and prevent complications.
Blood, Serum
Phlebotomist

The Metabolic Syndrome & Glucose Control Panel evaluates key biomarkers—fasting glucose, insulin, lipids, and related metrics—to assess insulin resistance, glucose dysregulation, and cardiometabolic risk. This integrated panel helps clinicians identify metabolic syndrome early, monitor glycemic control, and guide interventions to reduce progression to type 2 diabetes and cardiovascular disease.


The Diabetes Risk Panel with Score combines multiple biomarkers to assess risk of developing type 2 diabetes and related metabolic conditions. By evaluating glucose control, insulin resistance, lipid levels, and inflammation markers, this panel provides a personalized score that reflects overall metabolic health. Clinicians use it to help identify individuals at increased risk, support early intervention, and monitor long-term health.


Serum, Blood
Phlebotomist

Blood, Serum
Phlebotomist


Serum, Blood
Phlebotomist

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.


The Cardio IQ™ Diabetes Risk Panel with Score combines advanced biomarker analysis to evaluate insulin resistance, lipid metabolism, and glycemic control. This panel generates a diabetes risk score that helps identify individuals at increased risk for type 2 diabetes and related cardiometabolic complications. It provides insight into metabolic health, supporting early intervention, lifestyle planning, and long-term disease management.


The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

Blood
Phlebotomist
Also Known As: A1c Test, HbA1c Test, Glycated Hemoglobin Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Serum
Phlebotomist
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Urinalysis Complete Test evaluates urine for physical, chemical, and microscopic properties to assess kidney health, urinary tract infections, diabetes, and metabolic disorders. It measures appearance, concentration, pH, protein, glucose, ketones, blood, bilirubin, nitrites, leukocyte esterase, and microscopic cells or crystals. Doctors use this test in routine exams, to diagnose urinary symptoms, and to monitor chronic kidney or metabolic disease.

Random
Phlebotomist
Also Known As: Urine Analysis Test, UA Test, Complete Urinalysis Test

Most Popular

The Insulin Test measures insulin levels in blood to assess how the body regulates glucose and metabolism. It helps diagnose insulin resistance, hypoglycemia, type 2 diabetes, and metabolic syndrome. Doctors also use it to evaluate pancreatic function and monitor treatment effectiveness. Frequently ordered with glucose testing, the insulin test provides critical insight into endocrine health, blood sugar control, and risk for diabetes-related complications.

Serum
Phlebotomist
Also Known As: Fasting Insulin Blood Test

Most Popular

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

Serum
Phlebotomist
Also Known As: Fasting Glucose Test, Fasting Blood Sugar Test


The Acetone Blood Test measures acetone, a type of ketone produced during fat metabolism. Elevated levels may indicate diabetic ketoacidosis, uncontrolled diabetes, starvation, or metabolic disorders. This test supports evaluation of unexplained acidosis, altered mental status, or symptoms such as nausea and rapid breathing, providing insight into metabolic balance and monitoring of critical illness or diabetes management.

Blood
Phlebotomist

The Adiponectin Test measures adiponectin, a hormone made by fat cells that helps regulate glucose levels and fatty acid breakdown. Low adiponectin is linked to insulin resistance, type 2 diabetes, obesity, and cardiovascular disease. Doctors use this test to evaluate metabolic health, assess risk for diabetes or heart disease, and monitor patients with weight-related or endocrine disorders. Results help guide prevention and treatment strategies.

Serum
Phlebotomist
Also Known As: Fat Metabolism Test

The Alpha-1-Antitrypsin Quantitative Test measures levels of alpha-1-antitrypsin (AAT), a protein that protects the lungs and liver from damage. Low levels may indicate alpha-1-antitrypsin deficiency, a genetic disorder linked to emphysema, COPD, and liver disease. Doctors use this test to investigate unexplained lung or liver problems, confirm hereditary AAT deficiency, and guide treatment or monitoring strategies for long-term health management.

Serum
Phlebotomist
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Serum Test

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

Serum
Phlebotomist
Also Known As: Apo A1 and B Test, Apolipoprotein Evaluation Test

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

Serum
Phlebotomist
Also Known As: BMP Test, Chemistry Panel, Chemistry Screen, Chem 7, Chem 11, SMA 7, SMAC7, Basic Metabolic Test, Chem Test, Chem Panel Test 

The Bilirubin Direct Test measures conjugated bilirubin in the blood to assess liver function and bile duct health. Elevated levels may indicate hepatitis, cirrhosis, gallstones, or bile duct obstruction, while low levels are generally normal. Doctors order this test for patients with jaundice, fatigue, or suspected liver disease. Results help diagnose and monitor liver disorders, guide treatment decisions, and evaluate overall hepatic and biliary health.

Serum
Phlebotomist
Also Known As: Direct Bilirubin Test

Most Popular

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.

Serum
Phlebotomist
Also Known As: Connecting Peptide Insulin Test, Proinsulin C-Peptide Test

Did you know that one in ten people living in the United States of America have diabetes? Even further, one in three people has prediabetes. So, the odds are that you know someone that has diabetes as well as multiple people who have prediabetes.

In fact, you may be one of them.

And, if you do have diabetes or prediabetes, you need to make sure that you're managing your health through diabetes management tests. This means that you need to manage your blood sugar levels, blood pressure, and more.

As long as these levels remain stable, you should be able to carry on with a normal way of life.

To learn more about diabetes management and how you can build your own treatment plan, keep reading. This information could save your life. 

What Is Diabetes Management?

Diabetes management refers to the things that you can do ... See more